Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and does not recommend the drug war coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    The Delaware Mass Overdose Drugs Aren’t “Naloxone-Resistant”

    On April 30, Delaware State Police (DSP) and the Delaware Department of Health and ...

    FDA Approves Even Higher-Dose Naloxone Nasal Spray, Again

    The Food and Drug Administration has approved a new naloxone nasal spray that contains ...

    If Abstinence Isn’t the Point of Contingency Management, What Is?

    There aren’t any treatments for stimulant use disorder (SUD) that have strong evidence, but ...

    The Campaign to Call Fentanyl Deaths “Poisoning” Is Working as Intended

    A basic concept of toxicology is that “the dose makes the poison.” Any substance ...

    CBP Launches Operation Plaza Spike, “Next Phase” in War on Fentanyl

    Customs and Border Protection (CBP) has begun the latest iteration of its synthetic drug ...

    CDC: Overdose Deaths Leveled Off in 2022, Still Setting New Record

    The United States recorded 107,941 drug overdose deaths in 2022, according to final data ...

    Oregon Lawmakers Recriminalize Drugs, Under the Guise of Treatment

    On March 1, Oregon legislators approved a bill to recriminalize drug possession, undoing the ...

    Many Drug Users Aren’t Protected by “Good Samaritan” Laws

    Kansas, one of the last two states without a “Good Samaritan” law for drug ...

    Nalmefene Is Not “Just Like Naloxone”

    Opvee, an opioid-overdose antidote manufactured by Indivior that was approved in 2023, has in ...